首页 › 基金 › NS Partners Ltd › ABBV

NS Partners Ltd 对 ABBV 的持仓历史

ABBVIE INC · 医疗保健

NS Partners Ltd 在 Q3 2026 的 13F 申报中披露持有 ABBV(ABBVIE INC)44,478 股,市值约 US$11.6M,约占其申报组合的 0.50%,在其申报持仓中市值排名第 50 位。 NS Partners Ltd 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)44.48K 股
申报持仓市值$11.63M
组合权重0.50%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

NS Partners Ltd 对 ABBV 的持仓演变

NS Partners Ltd 于 Q3 2026 首次披露 ABBV 持仓:44,478 股(约 US$11.6M)。

逐季持仓明细

季度股数金额变化
Q3 2026 44.48K $11.63M 新进

关于 ABBV 与 13F 数据

ABBV(ABBVIE INC)属于医疗保健行业。我们追踪的基金中还有 31 只申报持有 ABBV,申报仓位最大的包括:先锋集团 (US$41.31B), 贝莱德 (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABBV 的基金

查看 ABBV 的全部基金持有人 →

常见问题

How long has NS Partners Ltd held ABBV?

NS Partners Ltd has disclosed ABBV holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is NS Partners Ltd's current position in ABBV?

As of Q3 2026, NS Partners Ltd holds 44.48K shares of ABBV (ABBVIE INC), valued at $11.63M, representing 0.50% of its reported portfolio and ranking #50.

Has NS Partners Ltd been buying or selling ABBV?

In the latest 13F filing (Q3 2026), NS Partners Ltd newly opened its position in ABBV.

Which other funds hold ABBV?

Other major institutional holders of ABBV include 先锋集团, 贝莱德, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.